ALLERGIC RHINITIS

This early-stage study tested the safety of a new drug called INI-2004 for people with ragweed allergies (hay fever). First, healthy volunteers received single doses. Then, people with confirmed ragweed allergies received multiple weekly doses. The main goal was to check for side…

This early-stage study tested the safety and how the body processes a new nasal spray called PA9159, intended for treating allergic rhinitis (hay fever). It involved 36 healthy Chinese adults who received either the spray or a placebo for one day or seven days. The main goal was …

This study tested a new nasal spray called AD17002 to see if it is safe and can help control symptoms in adults allergic to house dust mites. Forty-eight participants with dust mite allergy received either the spray or a placebo (inactive substance) over three weeks. Researchers …

This study tested whether a special nutritional supplement could help children better control their asthma and hay fever symptoms. Forty children with these allergies took the supplement for six months. Researchers measured changes in their symptoms and looked at markers in their…

This study aimed to see how well two different nasal sprays worked to ease allergy symptoms like stuffy and runny noses. Fifty adults with proven allergic rhinitis used one of the sprays for two weeks. Doctors and patients tracked symptom changes to compare the sprays' effectiven…

This study tested whether acupuncture could relieve the stuffy nose caused by allergic rhinitis (hay fever). Researchers compared a specific acupuncture treatment plan to a standard allergy nasal spray (azelastine) over six weeks. The goal was to see if acupuncture could provide …

This study tested whether Ectoin allergy nasal spray and eye drops work better than a placebo spray and drops at relieving seasonal allergy symptoms. Forty-six adults with ragweed allergies used the products in a special chamber that exposed them to allergens. Researchers measure…

This study looked at the safety and effectiveness of the drug Xolair in teenagers with severe seasonal allergies that weren't controlled by standard allergy medicines. It involved 50 participants aged 12 to 18 and observed them for up to 24 weeks. The main goal was to see what si…

This study aimed to understand how pediatricians in France diagnose and manage allergic rhinitis (hay fever) in children. It observed over 1,000 children under 18 who had the condition. The goal was to gather information on current practices, including how many children might be …